The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions

P Collins, Jan Astermark, V Blanchette, S Bjorkman, K Fischer, K Casey, P Schroth, S Fritsch, M Oh, G Spotts, B Ewenstein

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)58-58
Issue numbers2
Publication statusPublished - 2008
EventXXVIIIth International Congress of the World Federation of Hemophilia, 2008 - Istanbul, Turkey
Duration: 2008 Jun 12008 Jun 5
Conference number: 28

Subject classification (UKÄ)

  • Hematology

Cite this